CD47 and neoplasm: Both in vitro and in vivo studies demonstrated that NAcp@CD47 could increase the polarization of M1-phenotype TAMs, help reduce tumor immunosuppression, and inhibit tumor growth by phagocytosis of macrophages and microglia.